News tagged with abiraterone

Related topics: prostate cancer

Abiraterone: Hint of considerable added benefit

Abiraterone acetate (abiraterone for short, trade name: Zytiga) has been approved in Germany since December 2012 for men with metastatic prostate cancer that is not responsive to hormone blockade, who only have mild symptoms ...

Jul 02, 2013
popularity1 comments 0

Subscribe to rss feed